INS and diabetes mellitus: In a study of 28 patients with diabetes of mean duration 8.66 years, 4-weeks treatment with the combination of lixisenatide and glargine increased glucose-stimulated insulin secretion (measured on intravenous glucose tolerance test performed 30-minutes after lixisenatide administration) to a greater extent than did 4-weeks treatment with either medication alone19.